TY - JOUR
T1 - Acute and chronic renal effects of recombinant human TGF-β2 in the rat
AU - Kelly, Francis J.
AU - Anderson, Sharon
AU - Thompson, Michele M.
AU - Oyama, Terry T.
AU - Kennefick, Thomas M.
AU - Corless, Christopher L.
AU - Roman, Richard J.
AU - Kurtzberg, Leslie
AU - Pratt, Bruce M.
AU - Ledbetter, Steven R.
PY - 1999/6
Y1 - 1999/6
N2 - The expression of transforming growth factor-β (TGF-β) correlates with the incidence of renal glomerular and interstitial injury, however, nothing is known of the effect of these proteins on renal hemodynamics. This study examines the renal hemodynamic and morphologic effects of recombinant human TGF-β2 in normal male Sprague Dawley rats. Acute infusion of TGF-β2 (1.2 μg/kg per min) induced no hemodynamic changes, except for a modest though significant fall in mean arterial pressure. Administering TGF-β2 at varying doses (20, 100, and 400 μg/kg) for 9 wk caused modest increases in systolic BP and proteinuria and minimal tubular interstitial fibrosis, however, renal hemodynamic end points were not significantly altered. TGF-β2 (800 μg/kg) was also administered to volume-depleted rats for 7 consecutive days. In contrast to the findings in volume-replete animals, administration of TGF- β2 to volume-depleted rats caused a marked reduction in GFR and medullary blood flow. Histologic fibrosis of the medullary vasa recta and cortical interstitium was seen, but glomeruli were unaffected. Thus, acute and short- term chronic TGF-β2 administration did not induce major renal changes in the volume-replete state, however, TGF-β2 combined with volume depletion caused medullary hypoperfusion and reduced GFR.
AB - The expression of transforming growth factor-β (TGF-β) correlates with the incidence of renal glomerular and interstitial injury, however, nothing is known of the effect of these proteins on renal hemodynamics. This study examines the renal hemodynamic and morphologic effects of recombinant human TGF-β2 in normal male Sprague Dawley rats. Acute infusion of TGF-β2 (1.2 μg/kg per min) induced no hemodynamic changes, except for a modest though significant fall in mean arterial pressure. Administering TGF-β2 at varying doses (20, 100, and 400 μg/kg) for 9 wk caused modest increases in systolic BP and proteinuria and minimal tubular interstitial fibrosis, however, renal hemodynamic end points were not significantly altered. TGF-β2 (800 μg/kg) was also administered to volume-depleted rats for 7 consecutive days. In contrast to the findings in volume-replete animals, administration of TGF- β2 to volume-depleted rats caused a marked reduction in GFR and medullary blood flow. Histologic fibrosis of the medullary vasa recta and cortical interstitium was seen, but glomeruli were unaffected. Thus, acute and short- term chronic TGF-β2 administration did not induce major renal changes in the volume-replete state, however, TGF-β2 combined with volume depletion caused medullary hypoperfusion and reduced GFR.
UR - http://www.scopus.com/inward/record.url?scp=0032997081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032997081&partnerID=8YFLogxK
M3 - Article
C2 - 10361864
AN - SCOPUS:0032997081
SN - 1046-6673
VL - 10
SP - 1264
EP - 1273
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 6
ER -